Trial Outcomes & Findings for Early Intervention for Children at Risk for Anxiety (NCT NCT00865306)

NCT ID: NCT00865306

Last Updated: 2010-10-13

Results Overview

Clinicians blind to treatment assignment rated the child's global improvement on anxiety, using the Clinician Global Impression-Anxiety Improvement scale (CGI-Anxiety, best value 1, worst value 7). Responders were considered those with "very much" or "much" improvement (CGI-Anxiety scores of 1 or 2)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

65 participants

Primary outcome timeframe

Post-Treatment (6-months from baseline)

Results posted on

2010-10-13

Participant Flow

Study recruitment for the controlled trial occurred between February 2001 and January 2004. Children were recruited from the outpatient child psychiatry clinic at a general hospital, as well as through print ads in local newspapers and parent magazines, email advertisements to hospital employees, and posters at local pediatrics practices.

We screened 103 children for the controlled trial, to enroll our target goal of 60-65 children. Of these 14 were ineligible (3 did not meet inclusion criteria, and 9 met exclusion criteria). Another 13 withdrew prior to completing baseline assessments, and 11 who did not complete baseline assessments were lost to follow-up. Thus 65 were enrolled.

Participant milestones

Participant milestones
Measure
Active CBT
This was parent-child CBT, administered to families individually over 6 months, and including six 1-hour parent-only sessions, followed by 8-13 1-hour child-parent sessions, and one final 1-hour parent-only session.
No Intervention (Wait-list Controls)
This was a 6-month wait-list control condition in which children received no intervention. After participating in the control condition, families who wanted it were offered the opportunity to receive the CBT intervention.
Controlled Trial
STARTED
34
30
Controlled Trial
COMPLETED
29
28
Controlled Trial
NOT COMPLETED
5
2
One-Year Follow-Up
STARTED
29
15
One-Year Follow-Up
COMPLETED
29
15
One-Year Follow-Up
NOT COMPLETED
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Active CBT
This was parent-child CBT, administered to families individually over 6 months, and including six 1-hour parent-only sessions, followed by 8-13 1-hour child-parent sessions, and one final 1-hour parent-only session.
No Intervention (Wait-list Controls)
This was a 6-month wait-list control condition in which children received no intervention. After participating in the control condition, families who wanted it were offered the opportunity to receive the CBT intervention.
Controlled Trial
Lost to Follow-up
1
1
Controlled Trial
Difficulty commuting
2
0
Controlled Trial
Improved btw baseline and first session
1
0
Controlled Trial
Sought treatment for conduct disorder
1
0
Controlled Trial
Withdrawal by Subject
0
1

Baseline Characteristics

Early Intervention for Children at Risk for Anxiety

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active CBT
n=34 Participants
No Intervention (Wait-list Controls)
n=30 Participants
Total
n=64 Participants
Total of all reporting groups
Age, Categorical
<=18 years
34 Participants
n=5 Participants
30 Participants
n=7 Participants
64 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age Continuous
5.4 years
STANDARD_DEVIATION 1.0 • n=5 Participants
5.4 years
STANDARD_DEVIATION 1.0 • n=7 Participants
5.4 years
STANDARD_DEVIATION 1.0 • n=5 Participants
Sex: Female, Male
Female
17 Participants
n=5 Participants
17 Participants
n=7 Participants
34 Participants
n=5 Participants
Sex: Female, Male
Male
17 Participants
n=5 Participants
13 Participants
n=7 Participants
30 Participants
n=5 Participants
Region of Enrollment
United States
34 participants
n=5 Participants
30 participants
n=7 Participants
64 participants
n=5 Participants

PRIMARY outcome

Timeframe: Post-Treatment (6-months from baseline)

Clinicians blind to treatment assignment rated the child's global improvement on anxiety, using the Clinician Global Impression-Anxiety Improvement scale (CGI-Anxiety, best value 1, worst value 7). Responders were considered those with "very much" or "much" improvement (CGI-Anxiety scores of 1 or 2)

Outcome measures

Outcome measures
Measure
Active CBT
n=34 Participants
No Intervention (Wait-list Controls)
n=30 Participants
Number of Responders Based on Clinician Global Impression-Anxiety Improvement
20 Participants
9 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Post-Treatment (6-months from baseline)

Number of children free of anxiety disorders, as assessed by clinicians blind to treatment condition.

Outcome measures

Outcome measures
Measure
Active CBT
n=34 Participants
No Intervention (Wait-list Controls)
n=30 Participants
Number of Children Free of Anxiety Disorders
17 Participants
5 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 1-Year Follow-Up

Population: We tabulated the number of children that were "much" or "very much" improved on anxiety since baseline. Note that the controls who were followed up at one-year were those who subsequently received CBT (after participating in the wait-list condition). Therefore the "No intervention (wait-list controls)" followed up here had actually received CBT.

Clinicians rated improvement on anxiety since baseline using the Clinical Global Impression-Anxiety Improvement scale (Best 1, Worst 7), with children considered responders if they were rated "1, very much improved" or "2, much improved." Note that rates for controls are for controls who were subsequently treated with CBT (after completing the wait-list control condition).

Outcome measures

Outcome measures
Measure
Active CBT
n=29 Participants
No Intervention (Wait-list Controls)
n=15 Participants
Number of Responders Using Clinical Global Impression-Anxiety Improvement at 1-Year Follow-Up
24 Participants
11 Participants

Adverse Events

Active CBT

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

No Intervention (Wait-list Controls)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dina R. Hirshfeld-Becker, PhD

Massachusetts General Hospital

Phone: 617-503-1408

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place